detailed analysis of the cellular origin as well as the biology of these tumor cells. These efforts, however, have been hampered by the fact that H or RS cells usually account only for a minority of cells within the cellular background in HD tissue. Most of the cell lines were derived from pleural effusions containing RS or H cells. Various hematopoietic cells, including lymphocytes, monocytes, and interdigitating reticulum cells, have been speculated to be the normal counterpart of RS and H cells (2, (4) (5) (6) (7) (8) (9) (10) . The majority of tumor cell lines, however, derived from HD that have been described so far were found to be related to lymphocytes (2, (4) (5) (6) (7) .
The histopathological as well as a number of clinical features of HD might reflect the unbalanced production of cytokines, e.g., B symptoms (night sweats, fever, weight loss), eosinophilia, acute phase reaction proteins, and thrombocytoffs. Subsequently the expression of various cytokines has been studied in HD-derived tumor cell lines (11) .
In this report we describe the morphologic, immunophenotypic, molecular genetic, and functional characterization of a novel HD-derived cell line (HD-MyZ) consisting of typical KS and H cells, which display myelomonocytoid characteristics. An in vivo model of HD could be established by xenotransplantation of HD-MyZ cells into SCID mice.
Materials and Methods
Case History. H and lLS cells were isolated from a pleural effusion of a 29-yr-old patient with HD refractory to multiple therapy regimen. In 1980 HD of nodular sclerosing type (stage Ilia) was diagnosed in patient MZ. Initial treatment consisted of combined chemo-and radiotherapy. The patient relapsed several times with disseminated manifestations, including abdominal, cervical, and axillary lymph nodes, right proximal humerus, and right iliac crest. In September 1991 tumor progression could be observed with evolution of pleural effusion, infiltration of psoas muscle, and multifocal bone marrow infiltration despite intensive chemotherapy.
In addition the patient complained of fevers unresponsive to antibiotics and antifungal therapy. The patient's general condition deteriorated rapidly and the patient died in November 1991. Due to the fact that a high number of H and lLS cells could be seen within the smear cytology of the pleural fluid, this was the first patient with HD from whom we made an attempt to derive a cell line.
Culture Conditions and Reagents. Cytoplasmic antigens were detected as described using cytocentrifuge preparations (12) . Cells were fixed with paraformaldehyde and treated with Triton X-100 (0.5%). After incubation with mAb, cells were stained with FITC-labeled goat anti-mouse IgG (Dianova). Detection ofmRNA by PCR. Total RNA was extracted from viable calls as described by Gough (14) . Purification of poly(A +) RNA from 10/~g of total RNA was performed using the Dynabead mlLNA Purification Kit (Dynal, Oslo, Norway). Detection of mlLNA by PCIL was performed as described by Wang et al. (15) using a Geneamp RNA PCR Kit (Perkin Elmer-Cetus, Ubedingen, Germany) and a thermocyder (Bachhofer, Reutlingen, Germany) according to the PCIL kit protocol. In detail, 1/~1 of the eluted poly(A +) mlLNA (total volume, 20/~1) was used for reverse transcription (ILT) with a sequence-specific downstream primer directly followed by a PCR amplification step using an upstream primer. To rule out false-positive results due to DNA contamination, we always ran negative controls without RT. Onethird of the PCIL volume was run on an agarose gd (1%). After transfer to a nylon membrane and UV crosslinking, filters were prehybridized in hybridization buffer (50%, vol/vol, formaldehyde, 6• SSC, 0.1% SDS) for 4 h at 55~ cDNA was hybridized with a 32p-labeled internal oligonucleotide complementary to a sequence between the upstream and downstream primers. Probes were labeled using a Y-oligonucleotide end-labding kit (British Biotechnology, Oxford, UK). Filters were hybridized for 16 h at 55~ Filters were then washed twice for 30 rain with 6x SSC, 0.1% SDS at 70~ Table 1 shows oligonucleotide sequences used for RT-PCR and hybridization as well as length of the expected PCP, products .
Xenotransplantation of Tumor
Southern Blotting and Hybridization Probes. Total cellular DNA was extracted and digested with restriction endonucleases using standard protocols (48) . 10/~g of digested DNA was electrophoretically separated in 1% agarose gels and transferred to nylon membranes (Genescreen Plus; DuPont Co., Wilmington, DE). Hybridization probes labeled with 32p using the oligo-primed labeling method (49) were used in 50% formamide, 2x SSC at 42~ (Tin,
-20~
Control DNA was extracted from placenta, the human Burkitt lymphoma lines BJAB, Namalwa, and BL60, as well as the T lymphoma cell line Jurkat.
To analyze the human Ig heavy chain gene and the TCtL-~ gene for rearrangements, a genomic 2.2-kb Sau3a fragment of the joining region (IgHj region) (50) and an 800-bp cDNA sequence 0UIL-b2) (51) were used, respectively. For the detection of EBV DNA the Bgl2 U fragment (nucleotides 13944-17016) (52) specific for the EBV internal repeat 1 (IlL 1) was used. (21) 408 CCTCCCAACTGCTTCCCCC IL-4R (22) 472 TCTTCCACCTTCGGGAAGTACG IL-5 (23) 368 CCCCACAGAAATTCCCACAAG IL-6 (24) 595 GGATTCAATGAGGAGACTTGCC IL-6R(p80) (25) 251 CATTGCCATTGTTCTGAGGTTC IL-7 (26) 402 CATGGTCAAAACGGATTAGGG IL-7R (27) 605 GCCCTCGTGGAGGTAAAGTGCC IL-8 (28) 308 GGACAAGAGCCAGGAAGAAACC IL-SR (29) 440 GGGGGACGCTATAGGATGTGGG IL-10 (30) 467 CCCTGACCTCCCTCTAATTTATC GM-CSF (31) 424 ATGTGGCTGCAGAGCCTGCTGC TNF-c~ (32) 450 GACAAGCCTGTACGGCATGTTG TNF-/~ (33) 421 CCTCAAACCTGCTGCTCACCTC TNF-R.I (34) 601 GTGGAAGTCCAAGCTCTACTCC TNF-RII (35) 468 CTGCCGATAAGGCCCGGGGTAC c-rayc (36) 564 CCGCCCGCGGCCACAGCGTCTG c-myb (37) 610 GCCTCCTTTAACTTCCACCCCC c-fgr (38) 520 GGCGGTGAAGACGCTGAAGCCG
441 GGTGCCACCTGTGGTCCACCTG p53 (42) 576 GGCCCCTGTCATCTTCTGTCCC TGF-/~ (43) 530 GCGCCCACTGCTCCTGTGACAGC restin (44) 420 GGCAGCTCAGCAGCTCCTCAGGT
IL~1,v(17)
308 GTCTCTGAATCAGAAATCCTTCTATC IL-1R, I(45) 548 GGTACAGGGATTCCTGCTATG c-kit (46) 452 CGGGAAGCCCTCATGTCTGAAC c-f ms (47) 491 CCATGGATGGGGCGACACGGGG   CGCAGGATGGCATGGGGGAGGGCATACCCC  GGCTCAATAAAAGGGCTGGGG  GTCAGTGTTGAGATGATGCTTTGAC  CTGGGGAGCTGGGGTTATAGGC  GCGAGGCTCAAAGTCGTCTGTTG  GCCTTTCCAAGAAGTTTTTCC  GGCCTGGGTGCCACCCTGCTCC  GGCCTGACTCTTTCTTGGCCC  CAAACTGCATAGCCACTTTCC  AGTAGTCTGTATTGCTGATGTC  CTCTCTTATTCTCACCGGC  GGGAGACTGGGCCATACGATAG  CTTCAAAAACTTCTCCACAAC  CACAAGGCCAGTTGGCAGGTTG  CAGGCTGGAGTACAGGGGCAC  CTGGCTCCCAGCAGTCAAAGGG  GGGCAATGATCCCAAAGTAGAC  AGTTCTACAGAGCGAAGGCTCC  CGATGTCCTCCAGGCAGCCCAG  GCTTCATCCCAGCATCAGGCAC  CCTCGGTGTCCGAGGACCTGGG  CTGCTCCTCCATCTTTCCACAG  GCCTGGGTAGGGGATTCGGCCC  GGTAATCCCATACAACCCTGAG  CATCCTGGCAATGTGAGAATGC  GTTCACTTGTGGCCCAGATAGG  GCCGGTCTCTCCCAGGACAGGC  GGCGGGGCGGGGCGGGGCGGG  AAGGTTTCGTCGTCATTGCAGTTGG  CATGTCAAATTTCACTGCTTCATCC  GGTGACCGTCGCTGGACTGGC  GCGAGGAAAGCCATGCCCTTTG  GGAGTGAAGGCGGCGTATAGGG   GCCAGTGGTAGCGCCAGAGGCGTACAGGG  GGAGAGAGCTGACTGTCCTGGCTGATGGAC  CTTCTTCTAGACACTGAAGATGTTTCAGTTC  CTCTTAAAGAGGCCAATTAGTAACGCACAG  GCCTCCAGGTTTGGCCTTCGAAGGTTATTTTC  CCGTTTCAGGAATCGGATCAGCTGCTTGTG  GGACATTTCGGCGGAGGATCTGTCCCCAGG  CCCCCTTGCACAGTTTGACTCTCCAGTGTG  GTGTCCTAACGCTCATACTTTTAGTTCTCC  CATCTGGTCGGTTGTGGCTC  CTCTAAAACATCTCCAGCACAGAAGAAGAC  GCTGATGGTTAGTAAGATAGGATCCATCTCC  GTTCTTTAGCACTCCTTGGCAAAACTGCAC  CACCTGAGATGGGAAAACCACCCCCCTGAG  GTGCTGGGACTACAGGCGTGAGCCACCGCG  GCTGGCCATCATGGTCAAGGGGCCCTTGAGC  GGGCCGATTGATCTCAGCGCTGAGTCGGTC  AGGGCTGAGGACTAGGTGGGGGATGCCATC  GCTTGAAGGAACTACTACTAAGCCCCTGG  GCTCCAGCAGCAGCTCCCTGGAGAGCTCG  GCAGGATAGTCCTTCCGAGTGGAGGGAGGC  CTGCTACAAGGCTGCAAGGGGCTCGCCAGG  GAGCTCAGTGAGCAGGATCCCAAAGGACC  CTTCAACACCCTGTCTGGTCTTGGCTGAGG  GGCACGCAGCCTCCCAAACACCCCACCTCC  AGGGCGTCAGGTGCAGCTGCCTGGACATC  CCTCAAAGCTGTTCCGTCCCAGTAGATTAC  GGGGCAGGGCCCGAGGCAGAAGTTGGCATG  GGGCGTTCCTCACCCCGACTGCCATGGTG  GATTGATGCATGGACCCTTGATGGAGTGGGCC  CATGGCTATTTGCTCTTCAGATGAACCACC  GGCCAACTCGTCATCCTCCATGATGGCGGG 
HD-MyZ Cells Display Myelomonoq/toid Features.
Phenotypic analysis of the cell line was performed by immunofluorescence using a flow cytometer and cytocentrifugation (Table  2) . RT-PCR was used for analysis of mRNA expression. Cells strongly expressed CD13 (MyT), MHC class II (HLA-DR), and CD68, but did not express either B or T cell lineage-associated antigens, thus indicating myelomonocytoid differentiation.
Cells were also positive for MHC class I, transfetfin receptor (CD71), CD10, and CD29 (integrin 81 chain). The activation antigen CD30 (Ki-1), which is strongly expressed on Recently, a novel intermediate filament-associated protein, designated restin, has been described, which is found to be expressed in in vitro cultured human peripheral blood monocytes. This novel marker appears to be abundantly expressed in RS cells (44) . Using RT-PCR analysis we were able to detect restin mRNA expression in HD-MyZ cells (Fig. 2) .
Germ Line Configuration of the IgH and the TCR-~ Loci in HD-MyZ.
Since HD-MyZ cells were lacking cell surface markers of lymphoid differentiation but revealed instead myelomonocytoid features (coexpression of CD13, HLA-DR, CD68, and restin), we were interested in further studying lymphoid commitment on a molecular genetic level. Using BamHI-or EcoRI-digested DNA from HD-MyZ cells no rearranged bands were detected with IgJ, region of TCR/$ probes (Fig. 3) .
Absence of EBV Genomes in HD-MyZ.
No EBV-specific sequences were detected in HD-MyZ (H) as well as the EBVnegative cell lines BJAB (B) and Jurkat (J). In the human Burkitt's lymphoma line Namalwa(N), which carries two integrated copies of the EBV genome (51), the 3.1-kb BamHI fragment (W) is clearly detected (Fig. 4) .
mRNA Expression of Oncogenes, Cytokines, and Cytokine
Receptors. We studied the mRNA expression of a number of well-characterized proto-oncogenes and suppressor genes.
As shown in Fig. 5 a, specific transcripts of p53, c-myc, and bob1 could be detected. In addition expression of N-ras and c-myb was also detected, whereas mRNA expression of bcl-2 and c-fgr oncogenes was not observed. Expression of the protooncogene c-f ms (CSF-1 receptor) could be observed after PMA stimulation for 8 h (Fig. 6 b) . Table 3 summarizes the expression of these genes in HD-MyZ cells.
Since part of the clinical symptoms and of the pathology of HD might be explained by the unbalanced production of tumor cell-derived cytokines, we were interested in studying the constitutive mRNA expression of cytokines and their receptors. HD-MyZ cells were found to constitutively express transcripts of IL-lc~, IL-1/$, IL-5, IL-6, IL-7, IL-8, IL-10, as well as IL-1 (type 1) receptors (Fig. 5 b) . In contrast, the cells did not express TNF-~ IL-3, or GM-CSF (Fig. 5 c) . Table 3 summarizes the data on cytokines and cytokine receptors.
In addition, we studied the regulation of cytokine and cytokine receptor expression after in vitro stimulation with phorbol esters. In vitro stimulation with PMA for 24 h induced the de novo expression of IL-SR mRNA (Fig. 6 a) .
Secretion of Cytokines. We assessed the secretion of IL-I/$, IL-6, and IL-8 into the cell-free supernatant of our cell line by ELISA. In accordance with our mRNA expression data, high levels of IL-8 and moderate levels of IL-6 and IL-1/$ could be detected in the supernatant of unstimulated HDMyZ cells. Stimulation with PMA for 40 h led to a marked increase in IL-6, IL-8, and IL-13 secretion (Table 4) . Xenotransplantation into SCID Mice. 106 cells were in- A Southern blot of BamHI-digested DNA was prepared as described in Fig. 3 and was hybridized with a probe specific for the EBV internal repeat 1 (EBV IR1).
No EBV-specific sequences were detected in HD-MyZ (/-/) as well as the EBV-negative cell lines BJAB (B) and Jurkat 0). In the human Burkitt's lymphoma line Namalwa (N), which carries two integrated copies of the EBV genome (53), the 3.1-kb BamHl W fragment (W) is clearly detected. and CD71, and revealed a phenotype corresponding to that of HD-MyZ cells (Fig. 8) . Cells from all these tumor sites were transferred into culture medium and showed the same growth characteristics.
Discussion
The pathogenesis of l i d and, at its center, the cdlular origin of the H or P,S cells still remain enigmatic. Almost every hematopoietic cell, including both B and T lymphocytes, monocytes/macrophages, myeloid cells, and interdigitating reticulum cells, has been speculated to be the normal counterpart (for review see reference 2). With the advent of several HD-derived tumor cell lines it has been possible to carry out detailed studies on the biology and the origin of these cells. Due to the fact that H or RS cells account only for a minority of cells within the bystander cells in HD tissue and that many attempts to cultivate H or RS cells failed, one has to bear in mind that those cell lines, which were successfully derived from HD, might only reflect a certain aspect of the disease. Thus, one has to be careful in drawing generalizations from these cell lines about the in vivo biology and origin of H or RS calls.
We describe the successful establishment of a novel H cell line, which was derived from the pleural fluid of a patient with HD of nodular sderosing type. The morphological analysis of the cells within the pleural effusion disclosed the typical features of RS and H cells, i.e., large multinucleated and mononucleated cells with prominent nudeoli. These cells were transferred into culture medium, grew adherently, and have been in continuous culture since November 1991. The immunophenotyping disclosed that the HD-MyZ cell line was devoid of B or T lineage-associated markers (Table 2) . HDMyZ cells were found to strongly express CD13, a cell surface antigen expressed on myelomonocytic cells. MHC HLA-DR, CD71, CD10, and cytoplasmic CD68 were also detected. This phenotype (CD13 +, CD68 + , HLA-DR +) is compatible with myelomonocytic differentiation (54, 55) . Repeated FCM analysis did not show any change in cell surface antigen expression. CD13 (identical to aminopeptidase-N) and CD10 (identical to neutral endopeptidase) are both metalloproteases. Both proteases are thought to be involved in the inactivation of regulatory peptides at the cell surface (56). CD30 expression was not observed on the cell surface of HD-MyZ cells. Interestingly, another HD-derived cell line (SU/KH-HD-1) displaying myelomonocytic features, i.e., CD14 expression, was also described to be devoid of the HDassociated activation antigen CD30 (3).
Analysis of IgH and TCR fl locus confirmed our assumption that HD-MyZ cells lack lymphoid commitment. To our knowledge HD-MyZ is the only HD-derived cell line that is devoid oflg or TCR rearrangement. Little is known about 106 cells/ml were incubated with culture medium in the presence or absence of 10 ng/ml PMA. After the indicated incubation period, cells were pelleted, cell-free supernatants were collected, and cytokine concentration was measured by ELISA.
the involvement of specific oncogenes in the pathogenesis of HD. Studies on oncogene expression in different HD-derived cell lines revealed a heterogeneous pattern. Frequently expressed proto-oncogenes were c-myc, c-myb, c-raf, and N-ras (57) . In our cell line specific transcripts for c-myc, c-myb, bcl-1, N-ras, and p53 tumor suppressor gene were detected.
Since HD-MyZ cells showed phenotypical characteristics of myelomonocytoid differentiation (CD13, CD68, MHC class II), we were interested in studying the expression of a recently described intermediate filament-associated protein designated restin (44) , which is found to be expressed at high levels in H and KS cells and in in vitro cultivated human peripheral blood monocytes. Specific restin transcripts were detected in HD-MyZ cells. Expression of the c-f ms proto- HD is clinically characterized by B symptoms, elevated acute phase reaction proteins, thrombocytosis, and histopathologo ically by sclerosis, eosinophilia, plasmocytosis, lymphocytic, and neutrophil reaction. These features might reflect the effects of tumor cell-derived cytokines. We therefore studied mRNA expression of various cytokines and cytokine receptors as well as the release of these cytokines into the supernatants. The pattern of cytokine production observed in HD-MyZ cells fits into the setting of monocytoid differentiation of this cell line and could explain some of the clinical and histopathological features of HD. Autocrine production of growth factors has been suggested to be involved in the pathogenesis of various hematologic malignancies. Thus, TNF-o~ has been proposed as autocrine growth factor in hairy cell leukemia (59), IL-I~ in acute myeloid leukemia (60) , and IL-6 in plasmocytoma (61) . Since some cytokines (IL-lo~, IL-1B, IL-6) were expressed constitutively in conjunction with their receptors, an autocrine growth model might also exist in HD-MyZ cells.
Recently IL-6 secretion as well as IL-6 receptor expression were observed in several H cell lines (HDLM-2, KM-H2) as well as in HD tissue (62, 11) . Neutralizing antibodies to recombinant IL-6, however, did not inhibit the growth of the cell lines tested (11) .
Using immunoperoxidase staining of tumor tissue, IL-1 expression was observed in 20 patients with HD and in patients with true histiocytic malignancies, whereas B or T cell lymphomas were devoid of IL-1 expression (63). The authors argued that this observation might provide further evidence for the relationship between RS cells and interdigitating reticulum cells. In the mean time IL-1 expression has been described in a variety of tumors. IL-1 has been discussed as an autocrine growth factor in acute myeloblastic leukemia (see above). Since HD-MyZ cells display monocytic features and simultaneously express IL-lcr IL-13, and IL-1 receptors, IL-1 appears to be a likely candidate for an autocrine growth factor. Further studies using neutralizing antibodies or antisense oligonucleotides are warranted to clarify this model.
Due to the fact that HD-MyZ constitutively secretes large amounts of IL-8 in the absence of IL-8 receptors (which, however, can be induced by PMA treatment), IL-8 might have an important role as a paracrine rather than an autocrine cytokine. IL-8 might be responsible for inflammatory symptoms in patients with HD.
One important criterion for defining an in vitro growing cell as malignant is the tumorigenic growth in nude or SCID mice. In addition SCID mice provide a useful in vivo model for studying human lymphoma growth and in vivo therapy strategies (64) . The subcutaneous and intravenous inoculation of HD-MyZ cells into SCID mice led to the development of large tumor masses with infiltrative, destructive growth and to the evolution of extensive lymphadenopathy and splenomegaly. Histologically RS and H cells could be detected in these tissues. FCM analysis of human cells derived from these SCID mice tumors revealed the same phenotype as the parental in vitro cell line.
Due to the fact that the patient-derived cell line led to the development of disseminated tumors in SCID mice mimicking the patient's clinical picture concerning the localization of disease manifestations, we have reason to assume that this cell line indeed represents the disease-causing tumor cell. Taken together our data might suggest the following pathogenetical model: an activated myelomonocytic tumor cell with morphological characteristics of H or RS cells furnished with a broad repertoire of cytokines might cause the tissue reaction, as well as the biological heterogeneity observed in HD, and might sustain its growth in an autocrine fashion. The model using SCID mice might be of great value for understanding the biological heterogeneity of HD and for testing novel therapeutic interventions in vivo.
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